Screening Asymptomatic Kidney Transplant Candidates—<i>Primum Non Nocere</i>

Beckman, Joshua A.; McEvoy, Matthew D.

doi:10.1001/jamainternmed.2020.2674

JAMA Intern Med

2020

DOI: 10.1001/jamainternmed.2020.2674

|View full text |Cite

Screening Asymptomatic Kidney Transplant Candidates—Primum Non Nocere

Joshua A. Beckman

Matthew D. McEvoy

Abstract: Improving Global Outcomes (KDIGO) clinical practice guideline on the evaluation and management of candidates for kidney transplantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients experience the burden of frequent travel to and from transplant centers and financial repercussions . Noninvasive studies are often followed by invasive studies, such as cardiac computed tomography angiography or coronary angiography . Some patients with advanced chronic kidney disease experience rapid progression to ESKD because of nephrotoxic contrast agents used for cardiac imaging, such as invasive angiography.…”

mentioning

confidence: 99%

Coronary Heart Disease Testing Before Kidney Transplant—A Call for Revised Guidance

2023

View full text Add to dashboard Cite

End-stage kidney disease (ESKD) is a debilitating chronic illness for which kidney transplant is the treatment of choice, as it reduces mortality, improves quality of life, and lowers costs compared with dialysis. Professional societies recommend cardiac evaluation for transplant candidacy because patients with ESKD are at increased risk of cardiovascular disease. 1 There has been substantial debate regarding the risks and benefits of such pretransplant evaluation, but to our knowledge few clinical data. To fill this evidence gap, the study in a recent issue of JAMA Internal Medicine by Cheng and colleagues 2 examined the association between pretransplant coronary heart disease (CHD) testing in asymptomatic patients and early postoperative adverse events. Using Medicare data on all 79 334 patients undergoing first-time kidney transplant from 2000 to 2014, they found that pretransplant CHD testing was performed in 56% of patients at the most test-intensive transplant programs compared with 24% at the least testintensive programs. Routine pretransplant CHD testing was not associated with significant reduction in death or acute myocardial infarction within 30 days of transplant. In fact, they found a nonsignificant increase in adverse events at centers with higher rates of CHD testing. Cheng et al 2 were not able to include outcomes of CHD testing in patients who did not proceed to undergo transplant. While the consequences of such testing in patients who are not ultimately listed for transplant is unknown, to our knowledge there is no study in any population that shows a benefit to CHD testing in asymptomatic persons, with or without ESKD.This study should inform professional society guidelines surrounding pretransplant CHD testing. New guidelines from the American Heart Association and American College of Cardiology 3 (and endorsed by the American Society of Transplantation) recommend screening electrocardiogram and echocardiogram for asymptomatic patients with unknown CHD status before transplant listing, updating previous guidelines that recommended noninvasive stress testing regardless of functional status in patients with 3 or more risk factors (diabetes, greater than 1 year receiving dialysis, prior cardiovascular disease, left ventricular hypertrophy, older than 60 years, smoking history, hypertension, or dyslipidemia). 4 The nonprofit

show abstract

mentioning

confidence: 99%

Coronary Heart Disease Testing Before Kidney Transplant—A Call for Revised Guidance

2023

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Screening Asymptomatic Kidney Transplant Candidates—Primum Non Nocere

Abstract: Improving Global Outcomes (KDIGO) clinical practice guideline on the evaluation and management of candidates for kidney transplantation.

Cited by 1 publication

References 7 publications

Coronary Heart Disease Testing Before Kidney Transplant—A Call for Revised Guidance

Coronary Heart Disease Testing Before Kidney Transplant—A Call for Revised Guidance

Contact Info

Product

Resources

About